Search - tctmd.com

Displaying 121 - 135 of 135

Sort: Relevancy | Date

Presentation TCT 2012

The Potential of Otamixaban as a Procedural Anticoagulant

Presenter: Philippe Steg

October 24, 2012

Presentation TCT 2012

Contrarian Position: Oral Anticoagulants Introduce More Problems Than They Solve!

Presenter: Greg Mishkel

October 24, 2012

Presentation TCT 2012

Medical Therapy During Interhospital Transport: Fibrinolytic and/or Anticoagulant?

Presenter: Frans Van de Werf

October 24, 2012

Presentation TCT 2012

The New Anticoagulants: A Meaningful Step Forward?

Presenter: Gregg Stone

October 23, 2012

Presentation

Efficacy and Safety of the Novel Oral Anticoagulants in A-Fib: A Systematic Review and Meta-Analysis

Presenter: Francesco Dentali

October 18, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

Presentation

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Presenter: 62744|Gregg Stone

September 18, 2012

Presentation VEINS 2012

Anticoagulants: What is New in VTE

Presenter: John R. Bartholomew

September 14, 2012

Presentation

National Trends in Oral Anticoagulant Use in the United States, 2007-2011

Presenter: 205730|K Kirley

September 11, 2012

Presentation

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Presenter: 89964|William Baker

September 10, 2012

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

Presentation

Indirect Comparisons of New Oral Anticoagulant Drugs When Used for Stroke Prevention in A-fib

Presenter: GYH Lip

August 13, 2012

Presentation

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

Presenter: Corey S. Miller

May 03, 2012

Presentation

New Oral Anticoagulants for Stroke Prevention

Presenter: Nicole R. Gonzales

May 02, 2012

Presentation ISET 2012

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Presenter: Gregg W. Stone

January 15, 2012

Advertisement

The Potential of Otamixaban as a Procedural Anticoagulant

Contrarian Position: Oral Anticoagulants Introduce More Problems Than They Solve!

Medical Therapy During Interhospital Transport: Fibrinolytic and/or Anticoagulant?

The New Anticoagulants: A Meaningful Step Forward?

Efficacy and Safety of the Novel Oral Anticoagulants in A-Fib: A Systematic Review and Meta-Analysis

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Anticoagulants: What is New in VTE

National Trends in Oral Anticoagulant Use in the United States, 2007-2011

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Indirect Comparisons of New Oral Anticoagulant Drugs When Used for Stroke Prevention in A-fib

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

New Oral Anticoagulants for Stroke Prevention

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content